{
 "context": "The following article called 'Ligand: 1Q Earnings Snapshot' was published on 2018-05-09. The body of the article is as follows:\n    \nSAN DIEGO (AP) _ Ligand Pharmaceuticals Inc. (LGND) on Tuesday reported first-quarter net income of $45.3 million.\nThe San Diego-based company said it had net income of $1.83 per share. Earnings, adjusted for one-time gains and costs, came to $1.55 per share.\nThe drugmaker posted revenue of $56.2 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $32.3 million.\nLigand expects full-year earnings to be $4.85 per share, with revenue expected to be $184 million.\nLigand shares have risen 15 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $157.28, an increase of 40 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on LGND at https://www.zacks.com/ap/LGND\n\n    The day before the article was published, the stock price of Ligand Pharmaceuticals Incorporated was 157.27999877929688 and the day after the article was published, the stock price of Ligand Pharmaceuticals Incorporated was ",
 "expected": "171.75999450683594",
 "date": "2018-05-09",
 "ticker": "LGND",
 "company": "Ligand Pharmaceuticals Incorporated",
 "url": "https://www.cnbc.com/2018/05/08/the-associated-press-ligand-1q-earnings-snapshot.html"
}